Real World Evidence Solutions Market

1
Real World Evidence Solutions Market
2
As per a report by PS Intelligence, the
real-world evidence solutions market generated
revenue of USD 1,560 million in 2022, and it will
witness a compound annual growth rate of 12.40,
to reach USD 3,974 million by 2030.The growth
of the industry is due to the increasing number
of clinical trials, rising research and
development activities for medical devices and
drugs, and shifting focus from volume-based to
value-based healthcare.Request for sample pages
of this report https//www.psmarketresearch.com/m
arket-analysis/real-world-evidence-solutions-marke
t/report-sample Furthermore, RWE and RWD are
used to advance protocol designs, with the aim of
decreasing the number of expensive protocol
revisions. These solutions can also be used in
creating synthetic control arms, which will
fasten trial execution and decrease the overall
cost.Additionally, the rapid advancement in
volume, generation speed, and variety of data and
the necessity for quick insights are increasing
the demand for the right technologies for RWE
program implementation. Hence, numerous life
science companies are implementing cloud
technologies due to the speed, scalability,
flexibility, and safety they offer.In 2022, the
services category dominated the real-world
evidence solutions market with a more than 56
share, and it will remain dominant throughout
this decade. This is credited to the growing need
for decrease in the delays in drug development
and the availability of more healthcare
information that needs to be analyzed.
3
The data sets category is expected to grow at a
significant rate in the near future. This is
mainly because of the growing attention to gain
more insights into epidemiology and the
increasing amount of information generated in the
healthcare sector.The pharmaceutical and
medical device companies category will grow at
the highest CAGR, of 12.9, in the years to come.
This can be attributed to the need for the
elimination of the costly drug recalls and drug
performance evaluation in real-world settings and
the increasing importance of real-world evidence
(RWE) analyses in drug support.Additionally,
the pharmaceutical sector is increasingly using
real-world evidence to meet the governing
compliance necessities, along with the payer
requirements related to health economics and
outcomes research (HEOR).Browse full report
at https//www.psmarketresearch.com/market-analys
is/real-world-evidence-solutions-marketThe APAC
industry will grow at the highest CAGR, of
approximately 14, in the near future. The growth
is mainly credited to the increasing incidence of
chronic diseases, rising demand for advanced
healthcare services, existence of various
contract research organizations, growing number
of clinical trials, strong support of governments
for the adoption of RWE studies, and increasing
elderly population.It is because of the
increasing research and development expenditure,
rising demand for clinical and preclinical
services during the drug development process, and
increasing incidence of chronic diseases that the
real-world evidence solution demand will
considerably grow in the coming years.
4
Disclaimer PS Intelligence always keeps its
customers interests at the core while carrying
out research activities. PS Intelligence ensures
the reliability and accuracy of information and
data provided in its market research
publications. However, the information in
publications is subject to fluctuations, as it is
based on primary interviews of officials from
various companies or organizations. PS
Intelligence is not responsible for any incorrect
data provided by the key industry players of the
concerned domain. the information or analysis in
PS Intelligence publications represents opinions
based on research and should not be interpreted
as statements of fact. Information in this report
was believed to be correct at the time of
publication, but cannot be guaranteed. PS
Intelligence does not endorse any product,
service, or vendor depicted in its research
publications. All intellectual properties,
including trademarks and copyrights, belong to
their respective owners and may be protected by
copyright. Under no circumstance can these be
reproduced in any form without prior written
agreement of their owners. An order for market
research report is intended for internal use of
the company only and not for disclosure to third
parties or any other publication in general. No
service, report, or part thereof provided by PS
Intelligence can be reproduced, republished,
resold, revealed, distributed, circulated, or
sublicensed in any medium or form now realized or
hereafter become realized, including but not
limited to, all forms of optical-based media,
magnetic, electronic, or digital, without a
written permission from Prescient Strategic
Intelligence Pvt. Ltd.